Showing 1 - 10 of 171
Persistent link: https://www.econbiz.de/10015078462
Persistent link: https://www.econbiz.de/10011700583
Persistent link: https://www.econbiz.de/10003375857
In health care systems today, including those of Switzerland and the United States, participants do not necessarily see the big picture of lifetime health costs and quality of life, and in many systems consumers and providers lack the incentives to manage preventative and chronic care to...
Persistent link: https://www.econbiz.de/10003951552
Persistent link: https://www.econbiz.de/10003605599
Persistent link: https://www.econbiz.de/10003582911
The new Medicare Part D program provides prescription drug coverage for older Americans through highly subsidized and tightly regulated plans offered by private insurance firms. For most eligible individuals without coverage from other sources, obtaining Part D coverage would be rational, but it...
Persistent link: https://www.econbiz.de/10009571046
We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...
Persistent link: https://www.econbiz.de/10009571572
The new Medicare Part D program provides prescription drug coverage for older Americans through highly subsidized and tightly regulated plans offered by private insurance firms. For most eligible individuals without coverage from other sources, obtaining Part D coverage would be rational, but it...
Persistent link: https://www.econbiz.de/10009490186
We study the consequences of imposing a minimum coverage in an insurance market where enrollment is mandatory and agents have private information on their true risk type. If the regulation is not too stringent, the equilibrium is separating in which a single insurer monopolizes the high risks...
Persistent link: https://www.econbiz.de/10011311740